PubRank

Raffaele Scarpa

Author PubWeight™ 51.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005 2.39
2 Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012 2.18
3 Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 2011 1.52
4 Platelet reactivity and disease activity in subjects with psoriatic arthritis. J Rheumatol 2011 1.51
5 Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) 2012 1.46
6 Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 2006 1.19
7 Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis 2013 1.07
8 Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken) 2013 1.05
9 Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol 2011 1.02
10 Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 2011 1.02
11 The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis 2013 0.98
12 Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers. J Rheumatol 2012 0.98
13 Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. Clin Rheumatol 2010 0.97
14 Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists. Semin Arthritis Rheum 2005 0.97
15 Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol 2014 0.94
16 Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. Clin Rheumatol 2013 0.94
17 Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum 2005 0.92
18 Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers. J Rheumatol 2012 0.91
19 New developments in magnetic resonance imaging of the nail unit. J Rheumatol Suppl 2012 0.91
20 Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. Clin Exp Rheumatol 2011 0.90
21 Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther 2012 0.90
22 Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005 0.89
23 The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol 2014 0.87
24 Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol 2013 0.87
25 Dynamic contrast-enhanced magnetic resonance imaging of articular and extraarticular synovial structures of the hands in patients with psoriatic arthritis. J Rheumatol Suppl 2012 0.87
26 Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience. Semin Arthritis Rheum 2005 0.87
27 Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 2012 0.86
28 Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. J Rheumatol Suppl 2009 0.86
29 Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis. J Rheumatol Suppl 2012 0.86
30 Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) 2010 0.85
31 Osteoporosis and psoriatic arthritis. J Rheumatol Suppl 2012 0.84
32 JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunol Res 2014 0.83
33 Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study. Clin Exp Rheumatol 2010 0.83
34 Managing moderate-to-severe psoriasis in the elderly. Drugs Aging 2014 0.83
35 Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol 2011 0.82
36 Role of trauma in psoriatic arthritis. J Rheumatol 2008 0.82
37 The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. Clin Exp Rheumatol 2011 0.81
38 Etanercept in psoriatic arthritis. J Rheumatol Suppl 2012 0.81
39 TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis. Intern Emerg Med 2011 0.81
40 Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues. Clin Exp Rheumatol 2011 0.80
41 Body mass and osteoarthritic pain: results from a study in general practice. Clin Exp Rheumatol 2013 0.80
42 Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments. J Rheumatol 2014 0.80
43 Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study. Immunol Res 2015 0.79
44 Etanercept in spondyloarthropathies. Part I: current evidence of efficacy. Clin Exp Rheumatol 2011 0.79
45 The occurrence of lower limb enthesopathy in coeliac disease patients without clinical signs of articular involvement. Rheumatology (Oxford) 2013 0.79
46 Discovertebral erosions in patients with enteropathic spondyloarthritis. J Rheumatol 2012 0.78
47 Magnetic resonance imaging of the hand in psoriatic arthritis. J Rheumatol Suppl 2009 0.78
48 Dactylitis or "sausage-shaped" digit. J Rheumatol 2007 0.78
49 Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. Expert Opin Biol Ther 2015 0.78
50 Magnetic resonance imaging of nail unit in psoriatic arthritis. J Rheumatol Suppl 2009 0.78
51 The enthesopathy of celiac patients: effects of gluten-free diet. Clin Rheumatol 2014 0.77
52 Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis. Int J Colorectal Dis 2004 0.77
53 Growth hormone/insulin-like growth factor-I system and connective tissues: basic aspects and clinical implications. Rheum Dis Clin North Am 2005 0.77
54 Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement. Respir Med 2007 0.76
55 Transcriptional network profile on synovial fluid T cells in psoriatic arthritis. Clin Rheumatol 2015 0.76
56 Leflunomide in psoriatic polyarthritis. J Clin Rheumatol 2002 0.75
57 Efficacy of tocilizumab in a patient with refractory psoriatic arthritis. Clin Rheumatol 2014 0.75
58 Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity. Expert Opin Biol Ther 2014 0.75
59 Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept. Int J Rheum Dis 2013 0.75
60 Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting. J Rheumatol 2012 0.75
61 Thalassemic trait prevalence in patients affected by psoriatic arthritis in anti-TNF treatment. Drug Dev Res 2014 0.75
62 Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis. Clin Rheumatol 2011 0.75
63 The characteristics of symptomatic osteoarthritis in general and specialist practice in Italy: design and methods of the AMICA Study. Semin Arthritis Rheum 2005 0.75
64 Lack of efficacy of azathioprine in the treatment of axial arthritis complicating Crohn's disease. J Crohns Colitis 2008 0.75
65 The radiological assessment of axial involvement in psoriatic arthritis. J Rheumatol Suppl 2012 0.75
66 Detecting clinical activity in systemic lupus erythematosus with an archaeal poly(ADP-ribose) polymerase-like thermozyme: a pivotal study. Biomarkers 2009 0.75
67 The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. Clin Exp Rheumatol 2014 0.75